Assessment of Piperacillin-Tazobactam-Meropenem Synergy against Serine Carbapenemase-Producing EnterobacteralesUsing Time-Kill Assays

MLA

Lawandi, Alexander, et al. “Assessment of Piperacillin-Tazobactam-Meropenem Synergy against Serine Carbapenemase-Producing EnterobacteralesUsing Time-Kill Assays.” Antimicrobial Agents and Chemotherapy, vol. 65, no. 4, Feb. 2021. EBSCOhost, https://doi.org/10.1128/AAC.02317-20.

APA

Lawandi, A., Leite, G. C., Cheng, M. P., Lefebvre, B., Longtin, J., & Lee, T. C. (2021). Assessment of Piperacillin-Tazobactam-Meropenem Synergy against Serine Carbapenemase-Producing EnterobacteralesUsing Time-Kill Assays. Antimicrobial Agents and Chemotherapy, 65(4). https://doi.org/10.1128/AAC.02317-20

Chicago

Lawandi, Alexander, Gleice C. Leite, Matthew P. Cheng, Brigitte Lefebvre, Jean Longtin, and Todd C. Lee. 2021. “Assessment of Piperacillin-Tazobactam-Meropenem Synergy against Serine Carbapenemase-Producing EnterobacteralesUsing Time-Kill Assays.” Antimicrobial Agents and Chemotherapy 65 (4). doi:10.1128/AAC.02317-20.